Autoimmune hemolytic anemia in systemic lupus erythematosus at diagnosis: differences between pediatric and adult patients

Carregando...
Imagem de Miniatura
Citações na Scopus
32
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
SAGE PUBLICATIONS LTD
Citação
LUPUS, v.26, n.4, p.426-430, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective To determine the overall prevalence of autoimmune hemolytic anemia (AIHA), and to compare clinical and laboratory features in a large population of children and adult lupus patients at diagnosis. Methods This retrospective study evaluated the medical charts of 336 childhood-onset systemic lupus erythematosus (cSLE) and 1830 adult SLE (aSLE) patients followed in the same tertiary hospital. Demographic data, clinical features and disease activity were recorded. AIHA was defined according to the presence of anemia (hemoglobin <10g/dL) and evidence of hemolysis (reticulocytosis and positive direct antiglobulin test (DAT)/Coombs test) at SLE diagnosis. Evans syndrome (ES) was defined by the combination of immune thrombocytopenia (platelet count <100,000/mm(3)) and AIHA. Results The frequency of AIHA at diagnosis was significantly higher in cSLE patients compared to aSLE (49/336 (14%) vs 49/1830 (3%), p=0.0001), with similar frequency of ES (3/336 (0.9%) vs 10/1830 (0.5%), p=0.438). The median of hemoglobin levels was reduced in cSLE vs aSLE patients (8.3 (2.2-10) vs 9.5 (6.6-10) g/dL, p=0.002) with a higher frequency of multiple hemorrhagic manifestations (41% vs 7%, p=0.041) and erythrocyte transfusion due to bleeding (24% vs 5%, p=0.025). cSLE patients also had more often constitutional involvement (84% vs 31%, p<0.001), fever (65% vs 26%, p<0.001), weight loss>2kg (39% vs 6%, p<0.001), reticuloendothelial manifestations (48% vs 8%, p<0.001), hepatomegaly (25% vs 2%, p<0.001) and splenomegaly (21% vs 2%, p=0.004). Other major organ involvements were common but with similar frequencies in cSLE and aSLE (p>0.05). Median systemic lupus erythematosus disease activity index 2000 (SLEDAI-2K) was comparable in cSLE and aSLE (p=0.161). Conclusions We identified that AIHA was not a common condition in cSLE and aSLE, with distinct features characterized by a higher prevalence/severity in children and concomitant constitutional symptoms in the majority of them.
Palavras-chave
Autoimmune hemolytic anemia, childhood, adult, systemic lupus erythematosus
Referências
  1. Abbott JK, 2015, IMMUNOL ALLERGY CLIN, V35, P637, DOI 10.1016/j.iac.2015.07.009
  2. Aleem A, 2014, ACTA REUMATOL PORT, V39, P236
  3. Araujo DB, 2012, LUPUS, V21, P872, DOI 10.1177/0961203312441047
  4. BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185
  5. Brunner HI, 2008, ARTHRITIS RHEUM, V58, P556, DOI 10.1002/art.23204
  6. Duran S, 2008, ARTHRIT RHEUM-ARTHR, V59, P1332, DOI 10.1002/art.24020
  7. Fayyaz A, 2015, LUPUS SCI M IN PRESS
  8. Gladman DD, 2002, J RHEUMATOL, V29, P288
  9. Gokce M, 2012, LUPUS, V21, P878, DOI 10.1177/0961203312443721
  10. Gomes RC, 2016, ARTHRITIS C IN PRESS
  11. Gonzalez-Naranjo LA, 2016, SEMIN ARTHRITIS RHEU, V45, P675, DOI 10.1016/j.semarthrit.2015.11.003
  12. Gormezano NWS, 2016, SEMIN ARTHRITIS RHEU, V45, P706, DOI 10.1016/j.semarthrit.2015.10.015
  13. Gormezano NWS, 2015, PEDIATR INFECT DIS J, V34, P905, DOI 10.1097/INF.0000000000000756
  14. Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
  15. Jeffries M, 2008, LUPUS, V17, P739, DOI 10.1177/0961203308090990
  16. Livingston B, 2011, LUPUS, V20, P1345, DOI 10.1177/0961203311416694
  17. Lube GE, 2016, PEDIATR BLOOD CANCER, V63, P1238, DOI 10.1002/pbc.25976
  18. Oliveira JB, 2010, BLOOD, V116, pE35, DOI 10.1182/blood-2010-04-280347
  19. Silva CA, 2016, EXPERT REV CLIN IMMU, V12, P301, DOI 10.1586/1744666X.2016.1123621
  20. Sultan SM, 2003, RHEUMATOLOGY, V42, P230, DOI 10.1093/rheumatology/keg069
  21. Thakur N, 2015, INDIAN J HEMATOL BLO, V31, P68, DOI 10.1007/s12288-014-0357-5